167 related articles for article (PubMed ID: 322009)
41. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
Barras JP; Michal M
Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
[No Abstract] [Full Text] [Related]
42. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
Freyler H; Sehorst W
Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
[No Abstract] [Full Text] [Related]
43. Double-blind clinical and plethysmographic study of calcium dobesilate in patients with peripheral microvascular disorders.
Hachen HJ; Lorenz P
Angiology; 1982 Jul; 33(7):480-8. PubMed ID: 7046524
[No Abstract] [Full Text] [Related]
44. [The diabetic retinopathy in the ophthalmologic practice (author's transl)].
Zielinski HW
Klin Monbl Augenheilkd; 1975 Nov; 167(5):715-9. PubMed ID: 1206953
[TBL] [Abstract][Full Text] [Related]
45. [Effect of calcium dobesilate on blood hyperviscosity].
Fortschr Med; 1979 Mar; 97(9):422. PubMed ID: 428880
[No Abstract] [Full Text] [Related]
46. [Sound and unsound drug therapy in diabetic retinopathy].
Rintelen F; Meyer JP
Ophthalmologica; 1975; 170(2-3):239-43. PubMed ID: 1134740
[No Abstract] [Full Text] [Related]
47. [Early initiation recommended: calcium dobesilate in diabetic retinopathy].
Ophthalmologe; 1998 Jun; 95(6 Suppl):1-4. PubMed ID: 9702079
[No Abstract] [Full Text] [Related]
48. [Clinical study of calcium dobesilate in the treatment of cerebral circulatory insufficiency. Apropos of 30 cases].
Warembourg H; Jaillard J
Lille Med; 1974 Oct; 19(8 Suppl 3):886-9. PubMed ID: 4618592
[No Abstract] [Full Text] [Related]
49. [Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives on the prevention of diabetic microangiopathy. Clinical pharmacological study].
Guerrini M; Pieragalli D; Acciavatti A; Galigani C; Guideri F; Franchi M; Landini F; Burresi A; Messa GL; Frigerio C
Clin Ter; 1989 May; 129(4):271-85. PubMed ID: 2527121
[TBL] [Abstract][Full Text] [Related]
50. [A double blind clinical trial in cases of cvi with doxivenil gel and another gel containing only a heparinoid (authors transl)].
Berson I
Schweiz Rundsch Med Prax; 1976 Aug; 65(32):991-3. PubMed ID: 63122
[No Abstract] [Full Text] [Related]
51. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
52. Plethysmographic confirmation of the beneficial effect of calcium dobesilate in primary varicose veins.
Androulakis G; Panoysis PA
Angiology; 1989 Jan; 40(1):1-4. PubMed ID: 2642669
[TBL] [Abstract][Full Text] [Related]
53. Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
Javadzadeh A; Ghorbanihaghjo A; Adl FH; Andalib D; Khojasteh-Jafari H; Ghabili K
Mol Vis; 2013; 19():62-8. PubMed ID: 23335852
[TBL] [Abstract][Full Text] [Related]
54. The effect of calcium dobesilate on albumin leakage of the conjunctival vessels.
van Bijsterveld OP; Janssen PT
Curr Eye Res; 1981; 1(7):425-30. PubMed ID: 6797792
[TBL] [Abstract][Full Text] [Related]
55. Fluorescence iris angiography in the assessment of calcium dobesilate therapy in the treatment of diabetic microangiopathy.
Grignolo FM; Musso M; Borromeo P; Sebastiani F
Ophthalmologica; 1979; 178(5):250-8. PubMed ID: 91149
[TBL] [Abstract][Full Text] [Related]
56. A double-blind trial of calcium dobesilate in chronic venous insufficiency.
Casley-Smith JR
Angiology; 1988 Oct; 39(10):853-7. PubMed ID: 3177951
[TBL] [Abstract][Full Text] [Related]
57. Calcium dobesilate: A drug treatment for diabetic retinopathy can negatively interfere with the measurement of glycated albumin using the enzymatic method.
Guo X; Zhao F; Yin Y; Wang D; Hou L; Wu J; Li D; Cheng X; Xia L; Xu E; Qiu L
Clin Chim Acta; 2018 Aug; 483():1-5. PubMed ID: 29653084
[TBL] [Abstract][Full Text] [Related]
58. The action of calcium dobesilate on capillary permeability in diabetics.
Sévin R; Cuendet JF
Ophthalmologica; 1971; 162(1):33-40. PubMed ID: 5547865
[No Abstract] [Full Text] [Related]
59. Clinical pharmacology of phlebotropic drugs.
Cepeláková H; Petrlík M; Cepelák V; Roubal Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):714-23. PubMed ID: 94865
[TBL] [Abstract][Full Text] [Related]
60. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
